Study backs pulmonary delivery method for insulin
This article was originally published in Clinica
Executive Summary
Administering insulin to Type 1 diabetics using Aradigm's AERx pulmonary delivery system shows faster absorption and onset of metabolic effects, compared with subcutaneous injection, according to data presented at the American Diabetes Association meeting in San Antonio, Texas, last week.